N-[3-[5-(4-acetylphenoxy)-2-(difluoromethoxy)phenyl]-1-methylpyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-[1-(2-hydroxycyclobutyl)pyrazol-4-yl]oxyphenyl]-1-methylpyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
C51H42F4N14O8 — CID 165077730
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[5-(4-acetylphenoxy)-2-(difluoromethoxy)phenyl]-1-methylpyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-[1-(2-hydroxycyclobutyl)pyrazol-4-yl]oxyphenyl]-1-methylpyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
N-[3-[5-(4-acetylphenoxy)-2-(difluoromethoxy)phenyl]-1-methylpyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-[1-(2-hydroxycyclobutyl)pyrazol-4-yl]oxyphenyl]-1-methylpyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide (PubChem CID 165077730) has the molecular formula C51H42F4N14O8 and a molecular weight of 1054.98 g/mol. Its IUPAC name is N-[3-[5-(4-acetylphenoxy)-2-(difluoromethoxy)phenyl]-1-methylpyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-[1-(2-hydroxycyclobutyl)pyrazol-4-yl]oxyphenyl]-1-methylpyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide.
Molecular Properties
| Compound Name | N-[3-[5-(4-acetylphenoxy)-2-(difluoromethoxy)phenyl]-1-methylpyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-[1-(2-hydroxycyclobutyl)pyrazol-4-yl]oxyphenyl]-1-methylpyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide |
|---|---|
| PubChem CID | 165077730 |
| Molecular Formula | C51H42F4N14O8 |
| Molecular Weight | 1054.98 g/mol |
| Exact Mass | 1054.32 |
| IUPAC Name | N-[3-[5-(4-acetylphenoxy)-2-(difluoromethoxy)phenyl]-1-methylpyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-[1-(2-hydroxycyclobutyl)pyrazol-4-yl]oxyphenyl]-1-methylpyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide |
| SMILES | CC(=O)c1ccc(Oc2ccc(OC(F)F)c(-c3nn(C)cc3NC(=O)c3cnn4cccnc34)c2)cc1.Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Oc3cnn(C4CCC4O)c3)ccc2OC(F)F)n1 |
| InChI | InChI=1S/C26H20F2N6O4.C25H22F2N8O4/c1-15(35)16-4-6-17(7-5-16)37-18-8-9-22(38-26(27)28)19(12-18)23-21(14-33(2)32-23)31-25(36)20-13-30-34-11-3-10-29-24(20)34;1-33-13-18(31-24(37)17-11-30-34-8-2-7-28-23(17)34)22(32-33)16-9-14(3-6-21(16)39-25(26)27)38-15-10-29-35(12-15)19-4-5-20(19)36/h3-14,26H,1-2H3,(H,31,36);2-3,6-13,19-20,25,36H,4-5H2,1H3,(H,31,37) |
| InChIKey | UPGGAJADWZWHNX-UHFFFAOYSA-N |
| XLogP | 8.65 |
| TPSA | 246.26 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 77 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1054.98 |
| LogP ≤ 5 | 8.65 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 20 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 165077730 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.